ESLA Stock Analysis: Buy, Sell, or Hold?
ESLA - Estrella Immunopharma, Inc. Common Stock
$1.03
-0.14 (-11.91%)
▼
5d:
-2.77%
30d:
-22.51%
90d:
-66.21%
BUY
HIGH Confidence
Analysis Updated: Feb 4, 2026 12:00 AM ET
Get Alerted When ESLA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ESLA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ESLA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ESLA is currently trading at $1.03, which is considered slightly low relative to its 30-day fair value range of $0.96 to $1.36.
Technical Outlook: Technically, ESLA is showing sideways momentum. Immediate support is located at $0.90, while resistance sits at $1.21. Short-term momentum is weak, with the stock down 11.9% recently.
Market Sentiment: ESLA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.00 (+1267.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ESLA is showing sideways momentum. Immediate support is located at $0.90, while resistance sits at $1.21. Short-term momentum is weak, with the stock down 11.9% recently.
Market Sentiment: ESLA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.00 (+1267.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.96 -
$1.36
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.9%)
- BULLISH: Trading 1267.5% below Wall St target ($16.00)
Fair Price Analysis
30-Day Fair Range
$0.96 -
$1.36
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.90
Resistance Level
$1.21
Current Trend
Sideways
Technical data as of
Feb 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.62
Wall Street Target
$16.00
(+1267.5%)
Last updated: February 04, 2026 2:26 PM ET
Data refreshes hourly during market hours. Next update: 3:26 PM
Data refreshes hourly during market hours. Next update: 3:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ESLA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 66 BUY |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 52 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 64 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 53 HOLD |
